Search Results - "Abdel Wahab, Omar"

Intrusion Detection in the IoT Under Data and Concept Drifts: Online Deep Learning Approach by Abdel Wahab, Omar

“…Although the existing machine learning-based intrusion detection systems in the Internet of Things (IoT) usually perform well in static environments, they…”
Get full text

Deep and reinforcement learning for automated task scheduling in large‐scale cloud computing systems by Rjoub, Gaith, Bentahar, Jamal, Abdel Wahab, Omar, Saleh Bataineh, Ahmed

“…Summary Cloud computing is undeniably becoming the main computing and storage platform for today's major workloads. From Internet of things and Industry 4.0…”
Get full text

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation by Figueroa, Maria E., Abdel-Wahab, Omar, Lu, Chao, Ward, Patrick S., Patel, Jay, Shih, Alan, Li, Yushan, Bhagwat, Neha, Vasanthakumar, Aparna, Fernandez, Hugo F., Tallman, Martin S., Sun, Zhuoxin, Wolniak, Kristy, Peeters, Justine K., Liu, Wei, Choe, Sung E., Fantin, Valeria R., Paietta, Elisabeth, Löwenberg, Bob, Licht, Jonathan D., Godley, Lucy A., Delwel, Ruud, Valk, Peter J.M., Thompson, Craig B., Levine, Ross L., Melnick, Ari

“…Cancer-associated IDH mutations are characterized by neomorphic enzyme activity and resultant 2-hydroxyglutarate (2HG) production. Mutational and epigenetic…”
Get full text

Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities by Abdel-Wahab, Omar I., Healy, Brian, Dzik, Walter H.

“…BACKGROUND: Fresh‐frozen plasma (FFP) is frequently transfused to patients with mild prolongation of coagulation values under the assumption that FFP will…”
Get full text

Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms by Reiner, Anne S, Durham, Benjamin H, Yabe, Mariko, Petrova-Drus, Kseniya, Francis, Jasmine H, Rampal, Raajit K, Lacouture, Mario E, Rotemberg, Veronica, Abdel-Wahab, Omar, Panageas, Katherine S, Diamond, Eli L

“…Little is known about outcomes following interruption of targeted therapy in adult patients with histiocytic neoplasms. This is an IRB-approved study of…”
Get full text

A Survey on Explainable Artificial Intelligence for Cybersecurity by Rjoub, Gaith, Bentahar, Jamal, Wahab, Omar Abdel, Mizouni, Rabeb, Song, Alyssa, Cohen, Robin, Otrok, Hadi, Mourad, Azzam

“…The "black-box" nature of artificial intelligence (AI) models has been the source of many concerns in their use for critical applications. Explainable…”
Get full text

On the Detection of Passive Malicious Providers in Cloud Federations by Hammoud, Ahmad, Otrok, Hadi, Mourad, Azzam, Abdel Wahab, Omar, Bentahar, Jamal

“…Cloud federation has emerged as a new business architecture which aims to help cloud providers cope with the increased waves of demands on their resources and…”
Get full text

MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis by Weissman, Ran, Diamond, Eli L., Haroche, Julien, Durham, Benjamin H., Cohen, Fleur, Buthorn, Justin, Amoura, Zahir, Emile, Jean-François, Mazor, Roei D., Shomron, Noam, Abdel-Wahab, Omar I., Shpilberg, Ofer, Hershkovitz-Rokah, Oshrat

“…Erdheim–Chester disease (ECD) is characterized by excessive production and accumulation of histiocytes within multiple tissues and organs. ECD patients harbor…”
Get full text

Genome‐Wide Association Study Identifies the First Germline Genetic Variant Associated With Erdheim‐Chester Disease by Martínez‐López, Javier, Márquez, Ana, Pegoraro, Francesco, Ortiz‐Fernández, Lourdes, Acosta‐Herrera, Marialbert, Kerick, Martin, Gelain, Elena, Diamond, Eli L., Durham, Benjamin H., Abdel‐Wahab, Omar, Go, Ronald S., Koster, Matthew J., Dagna, Lorenzo, Campochiaro, Corrado, Collin, Matthew, Milne, Paul, Estrada‐Veras, Juvianee I., O'Brien, Kevin, Papo, Matthias, Cohen‐Aubar, Fleur, Amoura, Zahir, Haroche, Julien, Martín, Javier, Vaglio, Augusto

“…Objective Erdheim‐Chester disease (ECD) is rare histiocytosis with a wide range of clinical manifestations. Somatic mutations are key to the pathogenesis of…”
Get full text

Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy by Friedman, Joshua S., Durham, Benjamin H., Reiner, Anne S., Yabe, Mariko, Petrova‐Drus, Kseniya, Dogan, Ahmet, Pulitzer, Melissa, Busam, Klaus J., Francis, Jasmine H., Rampal, Raajit K., Ulaner, Gary A., Reddy, Ryan, Yeh, Randy, Hatzoglou, Vaios, Lacouture, Mario E., Rotemberg, Veronica, Mazor, Roei D., Hershkovitz‐Rokah, Oshrat, Shpilberg, Ofer, Goyal, Gaurav, Go, Ronald S., Abeykoon, Jithma P., Rech, Karen, Morlote, Diana, Fidai, Shiraz, Gannamani, Vedavyas, Zia, Maryam, Abdel‐Wahab, Omar, Panageas, Katherine S., Rosenblum, Marc K., Diamond, Eli L.

“…Summary Histiocytic neoplasms are diverse clonal haematopoietic disorders, and clinical disease is mediated by tumorous infiltration as well as uncontrolled…”
Get full text

Federated Machine Learning: Survey, Multi-Level Classification, Desirable Criteria and Future Directions in Communication and Networking Systems by Wahab, Omar Abdel, Mourad, Azzam, Otrok, Hadi, Taleb, Tarik

“…The communication and networking field is hungry for machine learning decision-making solutions to replace the traditional model-driven approaches that proved…”
Get full text

Cloud Computing as a Platform for Monetizing Data Services: A Two-Sided Game Business Model by Bataineh, Ahmed Saleh, Bentahar, Jamal, Mizouni, Rabeb, Abdel Wahab, Omar, Rjoub, Gaith, Barachi, May El

“…We argue in this paper that the role of the cloud should be reshaped from being a passive virtual market to become an active platform for monetizing data. The…”
Get full text

Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia by Stahl, Maximilian, Derkach, Andriy, Farnoud, Noushin, Bewersdorf, Jan Philipp, Robinson, Troy, Famulare, Christopher, Cho, Christina, Devlin, Sean, Menghrajani, Kamal, Patel, Minal A., Cai, Sheng F., Miles, Linde A., Bowman, Robert L., Geyer, Mark B., Dunbar, Andrew, Epstein‐Peterson, Zachary D., McGovern, Erin, Schulman, Jessica, Glass, Jacob L., Taylor, Justin, Viny, Aaron D., Stein, Eytan M., Getta, Bartlomiej, Arcila, Maria E., Gao, Qi, Barker, Juliet, Shaffer, Brian C., Papadopoulos, Esperanza B., Gyurkocza, Boglarka, Perales, Miguel‐Angel, Abdel‐Wahab, Omar, Levine, Ross L., Giralt, Sergio A., Zhang, Yanming, Xiao, Wenbin, Pai, Nidhi, Papaemmanuil, Elli, Tallman, Martin S., Roshal, Mikhail, Goldberg, Aaron D.

“…Measurable residual disease (MRD) is a powerful prognostic factor in acute myeloid leukemia (AML). However, pre‐treatment molecular predictors of…”
Get full text

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling by Ganzel, Chezi, Sun, Zhuoxin, Baslan, Timour, Zhang, Yanming, Gönen, Mithat, Abdel-Wahab, Omar I., Racevskis, Janis, Garrett-Bakelman, Francine, Lowe, Scott W., Fernandez, Hugo F., Ketterling, Rhett, Luger, Selina M., Litzow, Mark, Lazarus, Hillard M., Rowe, Jacob M., Tallman, Martin S., Levine, Ross L., Paietta, Elisabeth

“…Measurable residual disease (MRD) assessment provides a potent indicator of the efficacy of anti-leukemic therapy. It is unknown, however, whether integrating…”
Get full text

Therapeutic targeting of splicing in cancer by Lee, Stanley Chun-Wei, Abdel-Wahab, Omar

“…Patterns of splicing are frequently altered in cancer, and genes that encode splicing regulatory factors are often mutated. Thus, recent strategies have…”
Get full text

Splicing factor mutations in hematologic malignancies by Chen, Sisi, Benbarche, Salima, Abdel-Wahab, Omar

“…Mutations in genes encoding RNA splicing factors were discovered nearly 10 years ago and are now understood to be among the most recurrent genetic…”
Get full text

Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia by Shih, Alan H, Chung, Stephen S, Dolezal, Emily K, Zhang, Su-Jiang, Abdel-Wahab, Omar I, Park, Christopher Y, Nimer, Stephen D, Levine, Ross L, Klimek, Virginia M

“…Therapy-related myelodysplastic syndromes and acute myelogenous leukemia comprise a poor-risk subset of myelodysplastic syndromes and acute myelogenous…”
Get full text

Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia by Abdel-Wahab, Omar, Levine, Ross L.

“…Recent studies of the spectrum of somatic genetic alterations in acute myeloid leukemia (AML) have identified frequent somatic mutations in genes that encode…”
Get full text

Primary myelofibrosis: update on definition, pathogenesis, and treatment by Abdel-Wahab, Omar I, Levine, Ross L

“…Primary myelofibrosis (PMF) is a clonal stem cell disorder that manifests clinically as anemia, splenomegaly due to extramedullary hematopoiesis,…”
Get full text

Clinical Implications of Novel Mutations in Epigenetic Modifiers in AML by Abdel-Wahab, Omar, MD, Patel, Jay, BSc, Levine, Ross L., MD

“…Increased understanding of the molecular genetics of acute myeloid leukemia (AML) has uncovered several mutations in genes with a role in the epigenetic…”
Get full text